Fox Chase Cancer Center and Oryzon Genomics to Collaborate on Trial Investigating Safety and Efficacy of Iadademstat in Neuroendocrine and Small Cell Carcinomas

Press/Media

PeriodNov 17 2022

Media coverage

1

Media coverage

  • TitleFox Chase Cancer Center and Oryzon Genomics to Collaborate on Trial Investigating Safety and Efficacy of Iadademstat in Neuroendocrine and Small Cell Carcinomas
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date11/17/22
    PersonsJohnathan R. Whetstine, Hossein Borghaei